At Aeobiome, we’re not selling a supplement. We’re pioneering a therapeutic signalling platform built on postbiotics, engineered for consistency, precision, and systemic reach.At Aeobiome, we are building a platform—not just a product—that integrates formulation science, mechanistic validation, and real-world clinical deployment.A ecosystem was designed where science, care, and data come together to guide real, lasting outcomes. What’s being built is more than a product—it’s a new rhythm for how prevention is lived, daily.”

“A critical gap in chronic care delivery was identified—where gut-origin signalling was overlooked in systemic disease management. At Aeobiome, this gap has been addressed through the development of a stable, scalable postbiotic platform. Microencapsulated Trybutyrate has been positioned as a precision input, rather than a generic supplement.we’re building India’s first stable and scalable gut health platform—designed for doctors, backed by data, and driven by purpose.